TERRE BIO HOLDING: what changed
TERRE BIO HOLDING
Largest movements
- Cash -€184,353
down €184,353 (-92.9%), from €198,363 to €14,010
mainly Other debts (-€475,875) and Investment in fixed assets (net) (-€1,600)
- Receivables within one year -€158,193
down €158,193 (-99.8%), from €158,473 to €280
- Other debts -€475,875
down €475,875 (-65.8%), from €723,000 to €247,125
- Profit (loss) carried forward +€134,917
up €134,917 (+3,491%), from €3,864 to €138,781
- Financial charges -€235,930
down €235,930 (-100.0%), from €236,020 to €90
of which Non-recurring financial charges: -€235,733
- Financial income -€122,054
down €122,054 (-46.6%), from €261,957 to €139,903
- Gross operating margin +€2,217
up €2,217 (+36.3%), from -€6,115 to -€3,898
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,005,315 | €664,344 | -€340,971 | -33.9% |
| Fixed assets | 21/28 | €648,267 | €649,867 | +€1,600 | +0.2% |
| Financial fixed assets | 28 | €648,267 | €649,867 | +€1,600 | +0.2% |
| Current assets | 29/58 | €357,048 | €14,477 | -€342,571 | -95.9% |
| Amounts receivable within one year | 40/41 | €158,473 | €280 | -€158,193 | -99.8% |
| Other amounts receivable | 41 | €158,473 | €280 | -€158,193 | -99.8% |
| Cash at bank and in hand | 54/58 | €198,363 | €14,010 | -€184,353 | -92.9% |
| Deferred charges and accrued income | 490/1 | €211 | €187 | -€24 | -11.4% |
| Total equity and liabilities | 10/49 | €1,005,315 | €664,344 | -€340,971 | -33.9% |
| Equity | 10/15 | €280,064 | €414,981 | +€134,917 | +48.2% |
| Contributions | 10/11 | €94,000 | €94,000 | = | 0.0% |
| Capital | 10 | €94,000 | €94,000 | = | 0.0% |
| Issued capital | 100 | €94,000 | €94,000 | = | 0.0% |
| Reserves | 13 | €182,200 | €182,200 | = | 0.0% |
| Non-distributable reserves | 130/1 | €9,400 | €9,400 | = | 0.0% |
| Legal reserve | 130 | €9,400 | €9,400 | = | 0.0% |
| Distributable reserves | 133 | €172,800 | €172,800 | = | 0.0% |
| Profit (loss) carried forward | 14 | €3,864 | €138,781 | +€134,917 | +3,491% |
| Amounts payable | 17/49 | €725,250 | €249,363 | -€475,888 | -65.6% |
| Amounts payable within one year | 42/48 | €725,186 | €249,363 | -€475,823 | -65.6% |
| Trade debts | 44 | €2,186 | €2,238 | +€52 | +2.4% |
| Suppliers | 440/4 | €2,186 | €2,238 | +€52 | +2.4% |
| Other amounts payable | 47/48 | €723,000 | €247,125 | -€475,875 | -65.8% |
| Accrued charges and deferred income | 492/3 | €64 | - | -€64 | |
| Other operating charges | 640/8 | €1,018 | €998 | -€19 | -1.9% |
| Gross operating margin | 9900 | -€6,115 | -€3,898 | +€2,217 | +36.3% |
| Operating profit (loss) | 9901 | -€7,132 | -€4,897 | +€2,236 | +31.3% |
| Financial income | 75/76B | €261,957 | €139,903 | -€122,054 | -46.6% |
| Recurring financial income | 75 | €261,957 | €139,903 | -€122,054 | -46.6% |
| Financial charges | 65/66B | €236,020 | €90 | -€235,930 | -100.0% |
| Recurring financial charges | 65 | €287 | €90 | -€197 | -68.8% |
| Non-recurring financial charges | 66B | €235,733 | - | -€235,733 | |
| Profit (loss) for the period before taxes | 9903 | €18,805 | €134,917 | +€116,112 | +617% |
| Profit (loss) for the period | 9904 | €18,805 | €134,917 | +€116,112 | +617% |
| Profit (loss) for the period to be appropriated | 9905 | €18,805 | €134,917 | +€116,112 | +617% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.